IFF International Flavors & Fragrances Inc.
XNYS 85.43 DelayedStock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
What changed
Recent filings, trades and moves- 52-Week Range
- $61.73 – $95.27
- YTD
- +25.57%
- IV Rank (30D)
- 15.93
- Straddle Price
- $6.00
- P/C Vol Ratio
- 2.01
- Market Cap
- $20.7B
- Open
- $83.04
- Day Range
- $83.04 – $85.55
- Volume
- 1,043,024
- Prev Close
- $82.62
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 4.90% |
| Beta vs SPY | 1.00 |
| Cost of Equity (CAPM) | 9.90% (VRP-adj) |
| WACC | 9.03% |
| Volatility Risk Premium | +32.0pp (IV − HV30) |
| Effective Tax Rate | 33.5% |
| Rev. Growth (YoY, DCF input) | -10.0% |
| DCF Horizon | 10 years explicit + fade |
| Free Cash Flow (TTM) | $0.5B |
| Return on Equity (TTM) | 1.5% |
| Book / Price | 63.6% — banking bias active (P/B is primary) |
| Gross Margin (TTM) | 38.9% |
| FCF Margin (TTM) | 5.4% |
| Debt / Equity | 0.36 |
| Quality Score | 2/6 — normal (10y DCF) |
| Market-Implied Growth | +22.8% (reverse-DCF on current price) |
| SMA 50 | $87.08 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $90.49 |
| Bollinger Width / SMA20 | 13.7% (drives anchor stability) |
| Net Debt | $4.5B |
| Market Cap | $21B |
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $-2.83 | 0% | |
| DDM (Gordon) | $9.05 | 17% | |
| Peer P/E | $18.08 | 5% | median 23.8× · 6 peers |
| Peer EV/EBITDA | $50.85 | 6% | median 10.8× · 7 peers |
| Peer P/B | $183.33 | 8% | median 3.5× · 7 peers |
| Peer P/S | $117.06 | 8% | median 3.2× · 7 peers |
| Market Anchor (SMA50) | $87.08 | 34% | stability 81% (BB-width) |
| Options Expected (B-L 30d) | $84.14 | 21% | 30 strikes · skew +0.93 |

- Industry (SIC)
- INDUSTRIAL ORGANIC CHEMICALS (2860) · industry map
- Exchange
- XNYS
- Market Cap
- $20.7B
- Employees
- 21,500
- List Date
- 1964-03-02
- CIK
- 0000051253
- Last Earnings
- Nov 3 after close · −4.9% vs ±7.8% expected
- Next Earnings
- ~Feb 10, 2027 (estimated)
- Headquarters
- New York, NY
- Homepage
- https://www.iff.com
International Flavors & Fragrances is the largest specialty ingredients producer globally. It sells ingredients for the food, beverage, health, household goods, personal care, and pharmaceutical industries. The company makes proprietary formulations and partners with customers to deliver custom solutions. Through its taste and scent segments, which each generate 30% to 35% of profits, IFF is a leading flavor and fragrance producer. The health and biosciences business, which generates a little over 35% of profits, is a global leader in probiotics and enzymes.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | 6.95% | -11.53% | 6.46% | -0.91% | 4.81% | 2.62% | 1.40% |
| Feb | 4.12% | -0.82% | -17.89% | -8.13% | -5.31% | 17.89% | -1.69% |
| Mar | 0.33% | 2.27% | 0.35% | 13.32% | -4.09% | -10.15% | 0.34% |
| Apr | 2.39% | -9.70% | 7.02% | -1.99% | 1.33% | -3.27% | -0.70% |
| May | -1.70% | 8.72% | -20.09% | 14.51% | -1.66% | 7.40% | 1.20% |
| Jun | 4.98% | -9.87% | 3.90% | -0.92% | -2.85% | 6.68% | 0.32% |
| Jul | 0.84% | 4.02% | 6.12% | 6.81% | -5.41% | -1.83% | 1.76% |
| Aug | 1.28% | -11.72% | -16.45% | 5.21% | -2.84% | 7.14% | -2.90% |
| Sep | -11.13% | -16.39% | -2.96% | 1.30% | -7.53% | -2.68% | -6.57% |
| Oct | 4.50% | 5.17% | 3.61% | -3.58% | 3.30% | 11.91% | 4.15% |
| Nov | -1.33% | 10.86% | 10.76% | -7.65% | 11.92% | -9.72%* | 2.47% |
| Dec | 6.47% | -1.78% | 5.46% | -7.36% | -2.71% | -- | 0.02% |
| Total | 17.63% | -30.19% | -18.84% | 7.72% | -11.92% | 24.59% | -1.84% |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
LLM Stock Analysis Report: IFF
Executive Summary
Overall Assessment: NEUTRAL (Confidence Level: 6/10)
Key Drivers:
- Technical momentum signals are bullish, with a MACD crossover above the signal line.
- Recent news headlines suggest a positive sentiment, driven by the protein ingredients and confectionery markets.
Primary Risks:
- Beta is low at 0.80, indicating lower volatility than the market.
- Earnings data is not available, which may impact stock performance.
Investment Thesis: IFF has exhibited a neutral trend in recent weeks, with both technical and news sentiment aligning to support this assessment. The options market pricing a moderate move by expiration, indicating a relatively calm environment.
Recent News Sentiment Impact:
- The positive sentiment from the protein ingredients and confectionery markets may continue to drive stock performance.
- The lack of earnings data may limit potential catalysts for future price movements.
Technical Analysis
Trend Direction: Short-term: NEUTRAL (1-4 weeks), Medium-term: BULLISH (1-3 months)
Support/Resistance Levels: SMA 20: $75.41, SMA 50: $74.73, Upper Bollinger Band: $78.89
Momentum Signals:
- RSI (14) is at 51.28 (neutral), indicating no strong buying or selling pressure.
- MACD signal line crossover above the zero line suggests bullish momentum.
Volume Analysis: Volume SMA 20: 2086403.40, On-Balance Volume (OBV): -35443498.67, Volume Rate of Change: -80.56%
News & Sentiment Analysis
Recent Headlines Summary: Positive news headlines from the protein ingredients and confectionery markets have driven a neutral sentiment.
Sentiment Assessment: Aggregate news sentiment is NEUTRAL, with no strong buying or selling pressure.
Catalyst Identification: No specific catalysts are identified, but future earnings announcements could impact stock performance.
Market Narrative: Technical signals suggest a neutral trend, while news headlines support a positive sentiment.
Risk & Volatility Assessment
Beta Interpretation: Beta is low at 0.80, indicating lower volatility than the market.
Volatility Regime: Current vs historical volatility levels: Lower volatility (HV20 30.8%, HV30 31.5%, HV60 47.1%).
Options Market Signals: IV Rank: 15.1% (Low), Current IV: 49.2%, Expected Move: $4.35 (21 DTE)
Downside Protection: Support levels and risk management considerations are not applicable due to the neutral trend.
Market Context & Positioning
Sector Performance: Relative strength vs sector/market: Neutral.
Institutional Activity: Volume patterns suggesting institutional interest: Neutral.
Correlation Analysis: Correlation with market (R-squared interpretation): 0.29, indicating a relatively low correlation.
Relative Valuation: Position within trading range: Neutral.
Key Levels & Action Items
Critical Price Levels: SMA 20: $75.41, SMA 50: $74.73, Upper Bollinger Band: $78.89
Breakout/Breakdown Levels: No specific levels are identified due to the neutral trend.
Time-Sensitive Catalysts: Earnings announcements could impact stock performance in the future.
Risk Management: Stop-loss levels and position sizing considerations are not applicable due to the neutral trend.
By analyzing the technical indicators, news headlines, and risk metrics, IFF appears to be in a neutral trend. The options market is pricing a moderate move by expiration, indicating a relatively calm environment. While there are no specific catalysts driving stock performance, future earnings announcements could impact the price. A low beta and lower volatility levels suggest that the stock may be less affected by market fluctuations.
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2021-01-26 | After-Close | 2.15% | 2.50% | 1.16x | Exceeded |
| 2021-05-10 | After-Close | 5.10% | 2.82% | 0.55x | Within |
| 2021-08-05 | After-Close | 4.05% | 2.01% | 0.50x | Within |
| 2021-11-08 | After-Close | 5.63% | 3.79% | 0.67x | Within |
| 2022-02-09 | After-Close | 6.03% | 2.87% | 0.48x | Within |
| 2022-05-09 | After-Close | 7.28% | 5.03% | 0.69x | Within |
| 2022-08-08 | After-Close | 5.60% | 5.90% | 1.05x | Exceeded |
| 2022-11-07 | After-Close | 6.57% | 4.96% | 0.75x | Within |
| 2023-02-08 | After-Close | 5.29% | 18.75% | 3.54x | Exceeded |
| 2023-05-08 | After-Close | 8.16% | 7.03% | 0.86x | Within |
| 2023-08-07 | After-Close | 8.59% | 19.37% | 2.25x | Exceeded |
| 2023-11-06 | After-Close | 8.78% | 1.04% | 0.12x | Within |
| 2024-01-18 | After-Close | 1.44% | 1.49% | 1.03x | Exceeded |
| 2024-05-06 | After-Close | 8.10% | 6.40% | 0.79x | Within |
| 2024-08-06 | After-Close | 8.42% | 2.35% | 0.28x | Within |
| 2024-11-05 | After-Close | 7.16% | 11.63% | 1.62x | Exceeded |
| 2025-02-18 | After-Close | 8.30% | 5.16% | 0.62x | Within |
| 2025-05-06 | After-Close | 7.13% | 7.08% | 0.99x | Within |
| 2025-08-05 | Pre-Market | 7.23% | 0.67% | 0.09x | Within |
| 2025-11-04 | After-Close | 11.47% | 4.08% | 0.36x | Within |
| 2026-02-11 | Pre-Market | 7.62% | 0.27% | 0.04x | Within |
| 2026-05-05 | After-Close | 7.49% | 17.18% | 2.29x | Exceeded |
| 2026-08-04 | After-Close | 6.68% | 8.88% | 1.33x | Exceeded |
| 2026-11-03 | After-Close | 7.78% | 4.89% | 0.63x | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
IFF Options Activity & IV Rank
IFF IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Options Flow · All expiries
ATM Options Pricing
Chain Summary
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Calendars: the long leg is valued at the short leg’s expiration (Black-Scholes at its current IV) across the range of prices the short leg’s IV implies, giving the best-case profit (R/R = that over the debit) and P(profit).
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Scanning bull put, bear call, iron condor and calendar spreads…
Estimated net dealer gamma is at the 89th percentile of this name's own daily history, near the high end of its range. This describes current positioning; it is not a forecast or a trading signal.
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Loading the implied volatility surface…
Loading the implied volatility smile…
Risk Metrics
Analysis Details
Data Points: 251
Period: 252 trading days
Low volatility - stock moves less than market
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Icahn Capital / Icahn Enterprises Family office Carl Icahn, Brett Icahn | $338.7M | #6 of 15 | 0.0% | 13F + Form 4 · Director | |
| Millennium Management Hedge fund Izzy Englander | $119.1M | #288 of 3716 | +8361.2% | 13F | |
| Citadel Hedge fund Ken Griffin | $8.7M | #1690 of 6285 | -90.0% | 13F | |
| Bridgewater Associates Hedge fund Ray Dalio | $403K | #946 of 997 | new | 13F | |
| Rockefeller Capital Management Family office Rockefeller family | $310K | #2356 of 4729 | -3.4% | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
IFF Institutional Ownership (13F)
Filings for 2026-06-30 · 375 already for 2026-09-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Susquehanna International Group, LLP Custodian | $15.56M | 31.89% | 2026-06-30 |
| 2 | Twin Tree Management, LP | $7.87M | 16.12% | 2026-06-30 |
| 3 | Citadel Advisors LLC Custodian | $6.79M | 13.92% | 2026-06-30 |
| 4 | IMC-Chicago, LLC Custodian | $5.53M | 11.33% | 2026-09-30 |
| 5 | Jane Street Group, LLC Custodian | $5.22M | 10.70% | 2026-06-30 |
| 6 | Walleye Trading LLC | $4.66M | 9.55% | 2026-06-30 |
| 7 | Simplex Trading, LLC Custodian | $1.54M | 3.17% | 2026-09-30 |
| 8 | Walleye Capital LLC | $586.23K | 1.20% | 2026-06-30 |
| 9 | PEAK6 LLC | $419.87K | 0.86% | 2026-06-30 |
| 10 | Two Sigma Investments, LP Custodian | $348.57K | 0.71% | 2026-06-30 |
| 11 | HURRICANE CAPITAL ADVISORS LLC | $237.66K | 0.49% | 2026-06-30 |
| 12 | GROUP ONE TRADING LLC Custodian | $31.69K | 0.07% | 2026-06-30 |
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Susquehanna International Group, LLP Custodian | $14.58M | 47.65% | 2026-06-30 |
| 2 | Twin Tree Management, LP | $4.06M | 13.26% | 2026-06-30 |
| 3 | Citadel Advisors LLC Custodian | $3.59M | 11.73% | 2026-06-30 |
| 4 | Simplex Trading, LLC Custodian | $3.13M | 10.23% | 2026-09-30 |
| 5 | IMC-Chicago, LLC Custodian | $2.12M | 6.93% | 2026-09-30 |
| 6 | Jane Street Group, LLC Custodian | $1.39M | 4.56% | 2026-06-30 |
| 7 | GROUP ONE TRADING LLC Custodian | $570.38K | 1.86% | 2026-06-30 |
| 8 | Walleye Trading LLC | $538.70K | 1.76% | 2026-06-30 |
| 9 | Walleye Capital LLC | $324.80K | 1.06% | 2026-06-30 |
| 10 | Two Sigma Investments, LP Custodian | $293.11K | 0.96% | 2026-06-30 |
IFF Insider Trading (Form 4)
Latest: 2026-11-04| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-11-04 | Mehmood Khan | Director | Grant (A) | +1,215 RSU | — | EDGAR | |
| 2026-11-03 | J Erik Fyrwald | Chief Executive Officer | Grant (A) | +7,397 RSU | — | EDGAR | |
| 2026-08-19 | de Mendonca Ana Paula Teles | President, Scent | Sell (S) | −5,718 | $83.19 | -$475.7K | EDGAR |
| 2026-08-10 | Marc Birenkrant | Controller & CAO | Sell (S) | −1,000 | $85.00 | -$85.0K | EDGAR |
| 2026-08-07 | Michael DeVeau | EVP, CFO | Sell (S) | −8,825 | $85.55 | -$755.0K | EDGAR |
| 2026-06-02 | Paul J Fribourg | Director | Buy (P) | +273,500 | $74.29 | $20.32M | EDGAR |
| 2026-05-06 | Marc Birenkrant | Controller & CAO | Mixed Exer +389 · Tax −141 |
+248 | $70.09 | -$9.9K | EDGAR |
| 2026-05-06 | Deborah Borg | EVP, Chief Ppl&Culture Officer | Mixed Tax −713 · Exer +1,768 |
+1,055 | $70.09 | -$50.0K | EDGAR |
| 2026-05-06 | Michael DeVeau | EVP, CFO | Mixed Tax −452 · Exer +884 |
+432 | $70.09 | -$31.7K | EDGAR |
| 2026-05-06 | Ralf Finzel | EVP, Global Operations Officer | Mixed Tax −734 · Exer +1,326 |
+592 | $70.09 | -$51.4K | EDGAR |
| 2026-05-06 | de Mendonca Ana Paula Teles | President, Scent | Mixed Tax −362 · Exer +708 |
+346 | $70.09 | -$25.4K | EDGAR |
| 2026-05-05 | Jesus B Mantas | Director | Mixed | — | — | EDGAR | |
| 2026-05-05 | Cynthia T Jamison | Director | Mixed | — | — | EDGAR | |
| 2026-05-05 | Dawn C Willoughby | Director | Mixed | — | — | EDGAR | |
| 2026-05-05 | Paul J Fribourg | Director | Mixed | — | — | EDGAR |
IFF Insider Holdings
25 insiders · @ $85.49| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | J Erik Fyrwald | Chief Executive Officer | 126,069 | $10.78M | $5.84M | 11 | 2026-11-03 |
| 2 | Paul J Fribourg | Director | 43,559 | $3.72M | $32.28M | 6 | 2026-06-02 |
| 3 | Deborah Borg | EVP, Chief Ppl&Culture Officer | 38,638 | $3.30M | $0 | 14 | 2026-05-06 |
| 4 | Brett Icahn | Director | 34,712 | $2.97M | $0 | 4 | 2026-05-04 |
| 5 | Kevin O'Byrne | Director | 27,228 | $2.33M | $865.1K | 10 | 2026-05-04 |
| 6 | Ralf Finzel | EVP, Global Operations Officer | 18,355 | $1.57M | $0 | 12 | 2026-05-06 |
| 7 | Yuvraj Arora | President, Taste & CCO | 17,283 | $1.48M | -$458.8K | 8 | 2026-05-04 |
| 8 | Stephen N Landsman | EVP, General Counsel | 17,164 | $1.47M | $1.12M | 4 | 2026-04-03 |
| 9 | Simon Herriott | Pres. Health & Bioscience | 10,755 | $919.5K | $0 | 17 | 2025-03-06 |
| 10 | Angela Strzelecki | President, Pharma Solutions | 10,132 | $866.2K | -$247.6K | 16 | 2025-04-07 |
IFF Board & Officers
As of SEC filings through Nov 4, 2026Directors 12
- Mark J Costa · since Jan 1, 2023
- Dawn C Willoughby · since Feb 1, 2023
- Kevin O'Byrne · since Mar 10, 2023
- J Erik Fyrwald · since Feb 6, 2024
- Hernandez Margarita Palau · since Jun 3, 2024
- Cynthia T Jamison · since Jan 1, 2025
- Mehmood Khan · since Jan 1, 2025
- Virginia Drosos · since Jun 16, 2025
- Jesus B Mantas · since Jul 29, 2025
- Paul J Fribourg · since Jul 29, 2025
- Brett Icahn · since Oct 20, 2025
- Richard Mulligan · since Oct 20, 2025
Officers 10
- J Erik Fyrwald · Chief Executive Officer · since Feb 6, 2024
- de Mendonca Ana Paula Teles · President, Scent · since Apr 1, 2024
- Andres Roberto Muller · President, Food Ingredients · since Jan 1, 2025
- Leticia Goncalves Lourenco · President, Health & Bioscience · since Apr 1, 2025
- Yuvraj Arora · President, Taste & CCO · listed since Apr 2025
- Michael DeVeau · EVP, CFO · listed since May 2025
- Deborah Borg · EVP, Chief Ppl&Culture Officer · listed since Mar 2025
- Stephen N Landsman · EVP, General Counsel · since Apr 1, 2025
- Ralf Finzel · EVP, Global Operations Officer · since Nov 1, 2022
- Marc Birenkrant · Controller & CAO · since Aug 10, 2025
Changes in the last 10 years (81)
| Oct 20, 2025 | Richard Mulligan became a director |
| Oct 20, 2025 | Brett Icahn became a director |
| Oct 16, 2025 | The company announced the departure of Vincent J Intrieri from the board in an SEC filing |
| Aug 10, 2025 | Marc Birenkrant became Controller & CAO |
| Jul 29, 2025 | Paul J Fribourg became a director |
| Jul 29, 2025 | Jesus B Mantas became a director |
| Jun 16, 2025 | Virginia Drosos became a director |
| May 16, 2025 | Michael DeVeau listed as EVP, CFO (previously CFO) in SEC filings |
| Apr 2, 2025 | Yuvraj Arora listed as President, Taste & CCO (previously President, Nourish) in SEC filings |
| Apr 1, 2025 | Stephen N Landsman became EVP, General Counsel |
| Apr 1, 2025 | Leticia Goncalves Lourenco became President, Health & Bioscience |
| Mar 12, 2025 | The company announced the departure of Jennifer Amy Johnson as EVP, General Counsel in an SEC filing |
| Mar 6, 2025 | Deborah Borg listed as EVP, Chief Ppl&Culture Officer (previously EVP, Chief HR and D&I Officer) in SEC filings |
| Jan 1, 2025 | Vincent J Intrieri became a director |
| Jan 1, 2025 | Michael DeVeau became CFO |
| Jan 1, 2025 | Mehmood Khan became a director |
| Jan 1, 2025 | Cynthia T Jamison became a director |
| Jan 1, 2025 | Andres Roberto Muller became President, Food Ingredients |
| Dec 17, 2024 | The company announced the departure of Roger W. Ferguson Jr. from the board in an SEC filing |
| Dec 17, 2024 | The company announced the departure of Gaoxiang Hu from the board in an SEC filing |
| Dec 17, 2024 | The company announced the departure of Christina A Gold from the board in an SEC filing |
| Dec 17, 2024 | The company announced the departure of Carol Anthony Davidson from the board in an SEC filing |
| Jun 3, 2024 | Hernandez Margarita Palau became a director |
| May 3, 2024 | Simon Herriott listed as Pres. Health & Bioscience (previously Pres. Health & Biosci. & Scent) in SEC filings |
| May 1, 2024 | The company announced the departure of Glenn R Richter as CFO in an SEC filing |
| Apr 1, 2024 | de Mendonca Ana Paula Teles became President, Scent |
| Mar 5, 2024 | Simon Herriott listed as Pres. Health & Biosci. & Scent (previously President Health & Biosciences) in SEC filings |
| Feb 6, 2024 | J Erik Fyrwald became a director |
| Feb 6, 2024 | J Erik Fyrwald became Chief Executive Officer |
| Feb 5, 2024 | The company announced the departure of Barry A. Bruno from the board in an SEC filing |
| Jan 11, 2024 | The company announced the departure of Frank Clyburn as Chief Executive Officer in an SEC filing |
| Jun 19, 2023 | Yuvraj Arora became President, Nourish |
| Mar 10, 2023 | Kevin O'Byrne became a director |
| Feb 27, 2023 | The company announced the departure of Matthias Heinzel from the board in an SEC filing |
| Feb 27, 2023 | The company announced the departure of Edward D Breen from the board in an SEC filing |
| Feb 21, 2023 | The company announced the departure of Stephen Williamson from the board in an SEC filing |
| Feb 1, 2023 | The company announced the departure of Kare Schultz from the board in an SEC filing |
| Feb 1, 2023 | The company announced the departure of Dale F Morrison from the board in an SEC filing |
| Feb 1, 2023 | Gaoxiang Hu became a director |
| Feb 1, 2023 | Dawn C Willoughby became a director |
| Jan 25, 2023 | The company announced the departure of Ilene S Gordon from the board in an SEC filing |
| Jan 1, 2023 | Mark J Costa became a director |
| Dec 31, 2022 | Nicolas Mirzayantz left as President, Nourish, per their own SEC filing |
| Dec 27, 2022 | The company announced the departure of Michael L Ducker from the board in an SEC filing |
| Nov 1, 2022 | Ralf Finzel became EVP, Global Operations Officer |
| Sep 26, 2022 | Beril Yildiz became CAO, SVP & Controller |
| Aug 29, 2022 | Deborah Borg became EVP, Chief HR and D&I Officer |
| May 17, 2022 | The company announced the departure of Robert G. Anderson as Controller in an SEC filing |
| Mar 15, 2022 | The company announced the departure of Gonzalez Susana Suarez as EVP, Chief HR Officer in an SEC filing |
| Feb 14, 2022 | Frank Clyburn became Chief Executive Officer |
| Feb 8, 2022 | Barry A. Bruno became a director |
| Jan 20, 2022 | The company announced the departure of Andreas Fibig from the board in an SEC filing |
| Jan 20, 2022 | The company announced the departure of Andreas Fibig as CEO in an SEC filing |
| Oct 5, 2021 | Nicolas Mirzayantz listed as President, Nourish (previously Group President Fragrance) in SEC filings |
| Sep 27, 2021 | Glenn R Richter became CFO |
| Sep 1, 2021 | de Villeplee Christophe Fauchon became President, Scent |
| Feb 3, 2021 | Simon Herriott first on file as President Health & Biosciences |
| Feb 3, 2021 | Jennifer Amy Johnson first on file as EVP, General Counsel |
| Feb 3, 2021 | Angela Strzelecki first on file as President, Pharma Solutions |
| Feb 1, 2021 | Matthias Heinzel became a director |
| Feb 1, 2021 | Kathryn Jean Boor became a director |
| Feb 1, 2021 | Kare Schultz became a director |
| Feb 1, 2021 | Ilene S Gordon became a director |
| Feb 1, 2021 | Edward D Breen became a director |
| Feb 1, 2021 | Carol Anthony Davidson became a director |
| Oct 1, 2020 | Kathy Lynn Fortmann became Divisional CEO, Taste |
| Mar 12, 2020 | Peter Prast became a 10% owner |
| Mar 12, 2020 | Ernst Walch became a 10% owner |
| Feb 19, 2020 | Richard O'Leary listed as EVP & Integration Officer (previously EVP & Chief Financial Officer) in SEC filings |
| Jan 20, 2020 | Rustom Jilla became CFO |
| Oct 29, 2019 | Li-Huei Tsai became a director |
| Dec 20, 2018 | Matthias Haeni listed as Divisional CEO, Taste (previously Group President, Flavors) in SEC filings |
| Oct 4, 2018 | Amos Anatot became EVP and President, Frutarom |
| Aug 1, 2017 | Stephen Williamson became a director |
| Mar 2, 2017 | Winder Investment Pte Ltd became a 10% owner |
| Mar 2, 2017 | William Cornelius Lexmond became a 10% owner |
| Mar 2, 2017 | Kwai Ying Sharon Yam became a 10% owner |
| Mar 2, 2017 | Haldor Foundation became a 10% owner |
| Mar 2, 2017 | Freemont Capital Pte Ltd became a 10% owner |
| Dec 14, 2016 | Robert G. Anderson became Controller |
| Nov 28, 2016 | Gonzalez Susana Suarez became EVP, Chief HR Officer |
- Prev
- 1
- …
Not reported recently (27)
- Beril Yildiz · Last reported as CAO, SVP & Controller in an SEC filing dated May 19, 2025
- John Francis Ferraro · Last reported as a director in an SEC filing dated May 5, 2025
- Kathryn Jean Boor · Last reported as a director in an SEC filing dated May 5, 2025
- Angela Strzelecki · Last reported as President, Pharma Solutions in an SEC filing dated Apr 7, 2025
- Simon Herriott · Last reported as Pres. Health & Bioscience in an SEC filing dated Mar 6, 2025
- de Villeplee Christophe Fauchon · Last reported as President, Scent in an SEC filing dated May 12, 2023
- Gregory L Yep · Last reported as EVP, Chief Scientific Officer in an SEC filing dated May 5, 2023
- Francisco Fortanet · Last reported as EVP, Operations in an SEC filing dated Jan 5, 2023
- Winder Investment Pte Ltd · Last reported as a 10% owner in an SEC filing dated Sep 17, 2021
- Freemont Capital Pte Ltd · Last reported as a 10% owner in an SEC filing dated Sep 17, 2021
- Haldor Foundation · Last reported as a 10% owner in an SEC filing dated Sep 17, 2021
- Rustom Jilla · Last reported as CFO in an SEC filing dated Sep 17, 2021
- Kathy Lynn Fortmann · Last reported as Divisional CEO, Taste in an SEC filing dated May 7, 2021
- Anne Chwat · Last reported as EVP, GC, & Corp. Sec'y in an SEC filing dated Feb 2, 2021
- Matthias Haeni · Last reported as Divisional CEO, Taste in an SEC filing dated Jan 5, 2021
- Richard O'Leary · Last reported as EVP & Integration Officer in an SEC filing dated Dec 2, 2020
- Katherine M Hudson · Last reported as a director in an SEC filing dated Nov 4, 2020
- David R Epstein · Last reported as a director in an SEC filing dated Nov 4, 2020
- Marcello Bottoli · Last reported as a director in an SEC filing dated May 8, 2020
- Li-Huei Tsai · Last reported as a director in an SEC filing dated May 8, 2020
- Linda B Buck · Last reported as a director in an SEC filing dated May 5, 2020
- Peter Prast · Last reported as a 10% owner in an SEC filing dated Apr 16, 2020
- Ernst Walch · Last reported as a 10% owner in an SEC filing dated Apr 16, 2020
- Amos Anatot · Last reported as EVP and President, Frutarom in an SEC filing dated Jul 17, 2019
- Kwai Ying Sharon Yam · Last reported as a 10% owner in an SEC filing dated Oct 9, 2018
- William Cornelius Lexmond · Last reported as a 10% owner in an SEC filing dated Oct 9, 2018
- Henry W Howell Jr · Last reported as a director in an SEC filing dated Feb 13, 2018
IFF Proposed Insider Sales (Form 144)
Latest: 2026-08-17What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2026-08-17 | Teles de Mendonca Ana Paula | Officer | 5,718 | $475.7K | 2026-08-17 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-08-07 | Birenkrant Marc | Officer | 1,000 | $85.0K | 2026-08-07 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2026-08-06 | DeVeau Michael | Officer | 8,825 | $755.0K | 2026-08-06 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2025-11-07 | Yildiz Beril | Former Officer | 4,060 | $253.8K | 2025-11-07 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2025-05-19 | Yildiz Beril | Officer | 2,400 | $185.6K | 2025-05-19 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2024-11-12 | Arora Yuvraj | Officer | 5,000 | $458.8K | 2024-11-11 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2024-06-13 | Strzelecki Angela | Officer | 2,588 | $247.6K | 2024-06-13 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2023-05-11 | Fauchon de Villeplee Christophe | Officer | 1,972 | $170.3K | 2023-05-11 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| Filing Date | Event | Link |
|---|---|---|
| 2026-11-03 | Director or officer change · Bylaws or fiscal year change | EDGAR |
| 2026-11-03 | Earnings results | EDGAR |
| 2026-08-04 | Regulation FD disclosure | EDGAR |
| 2026-08-04 | Earnings results · Other events | EDGAR |
| 2026-06-23 | Material agreement · New debt obligation | EDGAR |
| 2026-06-01 | Material agreement · Other events | EDGAR |
| 2026-05-05 | Earnings results | EDGAR |
| 2026-05-04 | Shareholder vote results | EDGAR |
| 2026-02-11 | Earnings results | EDGAR |
| 2025-11-04 | Bylaws or fiscal year change | EDGAR |
| Filing Date | Accession | Link |
|---|---|---|
| 2026-11-03 | 0000051253-26-000041 | EDGAR |
| 2026-08-04 | 0000051253-26-000030 | EDGAR |
| 2026-05-05 | 0000051253-26-000017 | EDGAR |
| 2025-11-04 | 0000051253-25-000049 | EDGAR |
| 2025-08-05 | 0000051253-25-000042 | EDGAR |
| 2025-05-06 | 0000051253-25-000027 | EDGAR |
| 2024-11-05 | 0000051253-24-000042 | EDGAR |
| 2024-08-06 | 0000051253-24-000032 | EDGAR |
| 2024-05-06 | 0000051253-24-000016 | EDGAR |
| 2023-11-08 | 0000051253-23-000036 | EDGAR |
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.03% | $640.0M | — | 2026-09-30 |
| 2 | VOO Vanguard S&P 500 ETF | Vanguard | 0.03% | $559.4M | — | 2026-09-30 |
| 3 | IVV iShares Core S&P 500 ETF | iShares (BlackRock) | 0.03% | $283.4M | $852.9B | 2026-11-06 |
| 4 | XLB State Street® Materials Select Sector SPDR® ETF | SPDR (State Street) | 3.33% | $280.9M | $8.4B | 2026-11-05 |
| 5 | SPY State Street® SPDR® S&P 500® ETF Trust | SPDR (State Street) | 0.03% | $271.8M | $777.7B | 2026-11-05 |
| 6 | VB Vanguard Morningstar Small-Cap ETF | Vanguard | 0.13% | $227.8M | — | 2026-09-30 |
| 7 | VO Vanguard Morningstar Mid-Cap ETF | Vanguard | 0.10% | $216.6M | — | 2026-09-30 |
| 8 | RSP Invesco S&P 500 Equal Weight ETF | Invesco | 0.20% | $206.1M | — | 2026-11-05 |
| 9 | VBR Vanguard Morningstar Small-Cap Value ETF | Vanguard | 0.23% | $148.2M | — | 2026-09-30 |
| 10 | VTV Vanguard Morningstar Value ETF | Vanguard | 0.04% | $96.4M | — | 2026-09-30 |
| 11 | IWR iShares Russell Mid-Cap ETF | iShares (BlackRock) | 0.16% | $90.4M | $56.9B | 2026-11-06 |
| 12 | VYM Vanguard High Dividend Yield ETF | Vanguard | 0.09% | $86.9M | — | 2026-09-30 |
| 13 | VAW Vanguard Materials ETF | Vanguard | 1.45% | $65.3M | — | 2026-09-30 |
| 14 | VOE Vanguard Morningstar Mid-Cap Value ETF | Vanguard | 0.17% | $63.2M | — | 2026-09-30 |
| 15 | SPYM State Street® SPDR® Portfolio S&P 500® ETF | SPDR (State Street) | 0.03% | $61.8M | $177.9B | 2026-11-05 |
| 16 | DFAC Dimensional US Core Equity 2 ETF | Dimensional | 0.06% | $47.3M | — | 2026-11-05 |
| 17 | SPHQ Invesco S&P 500 Quality ETF | Invesco | 0.26% | $47.2M | — | 2026-11-05 |
| 18 | IWD iShares Russell 1000 Value ETF | iShares (BlackRock) | 0.06% | $46.6M | $82.9B | 2026-11-06 |
| 19 | IVE iShares S&P 500 Value ETF | iShares (BlackRock) | 0.07% | $35.3M | $50.4B | 2026-11-06 |
| 20 | DON WisdomTree U.S. Midcap Dividend Fund | Nport | 0.78% | $31.1M | — | 2026-06-30 |
| 21 | IWS iShares Russell Mid-Cap Value ETF | iShares (BlackRock) | 0.21% | $30.4M | $14.8B | 2026-11-06 |
| 22 | SPYV State Street® SPDR® Portfolio S&P 500® Value ETF | SPDR (State Street) | 0.07% | $28.0M | $38.2B | 2026-11-05 |
| 23 | ITOT iShares Core S&P Total U.S. Stock Market ETF | iShares (BlackRock) | 0.03% | $27.6M | $93.2B | 2026-11-06 |
| 24 | SCHX Schwab U.S. Large-Cap ETF | Nport | 0.03% | $23.4M | — | 2026-08-31 |
| 25 | IYM iShares U.S. Basic Materials ETF | iShares (BlackRock) | 2.20% | $22.7M | $1.2B | 2026-11-06 |
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q3 '26 | 2026-09-30 | $1.94B | $-55.00M | $-0.22 | $141.00M |
| Q2 '26 | 2026-06-30 | $1.95B | $50.00M | $0.20 | $436.00M |
| Q1 '26 | 2026-03-31 | $2.74B | $169.00M | $0.66 | $243.00M |
| Q4 '25 | 2025-12-31 | $2.59B | $31.00M | $0.12 | $318.00M |
| Q3 '25 | 2025-09-30 | $1.87B | $40.00M | $0.16 | $164.00M |
| Q2 '25 | 2025-06-30 | $1.92B | $599.00M | $2.33 | $241.00M |
| Q1 '25 | 2025-03-31 | $2.84B | $-1.02B | $-3.98 | $127.00M |
| Q4 '24 | 2024-12-31 | $2.77B | $-60.00M | $-0.23 | $389.00M |
| Q3 '24 | 2024-09-30 | $2.92B | $58.00M | $0.23 | $345.00M |
| Q2 '24 | 2024-06-30 | $2.89B | $170.00M | $0.66 | $237.00M |
| Q1 '24 | 2024-03-31 | $2.90B | $60.00M | $0.23 | $99.00M |
| Q4 '23 | 2023-12-31 | $2.70B | $-2.61B | $-10.21 | $644.00M |
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
IFF vs Peers
Related companies, largest first| Company | Market cap | P/E | Revenue growth | YTD | IV rank |
|---|---|---|---|---|---|
| LIN Linde plc Ordinary Share | $236.5B | 34.6 | +8.2% | +21.5% | 16 |
| NEM Newmont Corporation | $125.6B | 14.6 | +23.7% | +24.1% | 33 |
| FCX Freeport-McMoran Inc. | $85.3B | 30.9 | +0.2% | +20.8% | 46 |
| APD Air Products & Chemicals, Inc. | $67.9B | 33.0 | +3.7% | +24.5% | 21 |
| NUE Nucor Corporation | $55.6B | 19.7 | +17.2% | +45.9% | 67 |
| VMC Vulcan Materials Company(Holding Company | $36.3B | 34.3 | +1.6% | −0.7% | 59 |
| STLD Steel Dynamics Inc | $31.7B | 16.7 | +26.0% | +28.6% | 60 |
| IFF International Flavors & Fragrances Inc. | $20.7B | 112.5 | −1.9% | +25.7% | 16 |
| BALL Ball Corporation | $17.2B | 33.8 | +19.2% | +26.2% | 38 |
| Peer median | $61.7B | 31.9 | +12.7% | +24.3% | 42 |
P/E uses the latest reported trailing-12-month diluted EPS; "—" means no positive earnings or no data.
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.